title: Comment on 'Predicting the response to infliximab from trough serum levels'.
authors.forename: K
authors.initials: K
authors.lastname: Bendtzen
authors.forename: C
authors.initials: C
authors.lastname: Steenholdt
authors.forename: M
authors.initials: M
authors.lastname: Ainsworth
authors.forename: O Ø
authors.initials: OØ
authors.lastname: Thomsen
authors.forename: J
authors.initials: J
authors.lastname: Brynskov
mesh_terms: D000911:Antibodies, Monoclonal / Q000097:blood*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods*; D005765:Gastrointestinal Agents / Q000097:blood*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab